deltatrials
Unknown PHASE2 INTERVENTIONAL 2-arm NCT01279967

A Clinical Trial of ADI-PEG 20TM in Patients With Malignant Pleural Mesothelioma (ADAM)

A Randomized Stratified Multicentre Phase II Clinical Trial of Single Agent ADI-PEG 20TM (Pegylated Arginine Deiminase) in Patients With Malignant Pleural Mesothelioma

Sponsor: Barts & The London NHS Trust

Conditions Malignant Pleural Mesothelioma
Interventions ADI-PEG 20
Updated 5 times since 2017 Last updated: Nov 19, 2014 Started: Jan 31, 2011 Primary completion: Jan 31, 2015 Completion: Mar 31, 2015
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01279967, this PHASE2 trial focuses on Malignant Pleural Mesothelioma and remains ongoing. Sponsored by Barts & The London NHS Trust, it has been updated 5 times since 2011, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotUnknown Status~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotUnknown Status~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – present · 21 months · monthly snapshotUnknown

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE2

    Status: Unknown Status → Unknown

  3. Jan 2021 — Jul 2024 [monthly]

    Unknown Status PHASE2

  4. Jun 2018 — Jan 2021 [monthly]

    Unknown Status PHASE2

  5. Jan 2017 — Jun 2018 [monthly]

    Unknown Status PHASE2

    First recorded

Jan 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Barts & The London NHS Trust
  • Cancer Research UK
  • UK: Barts Center for Experimental Cancer Medicine (CECM) for Trial Coordination
Data source: Barts & The London NHS Trust

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations